Article Listing - BIOCRAFT APPROVAL

NIGERIAN HEALTH SPENDING FOR 1992

6 April 1992

The federal government of Nigeria has announced a total figure for health care spending in 1992 of 192 million naira,...

ARES-SERONO GAINS RIGHTS TO CUROSURF

6 April 1992

Swiss pharmaceutical group Ares-Serono has acquired exclusive marketing rights in most European territories for a natural pulmonary surfactant product, Curosurf,...

CHIROS ACQUIRES ENZYMATIX' CHIRAL DIV

6 April 1992

A new UK company, Chiros Ltd, was formed last month to purchase the assets and business of the Chiral division...

NEW PRES AT RHONE-POULENC RORER

6 April 1992

Rhone-Poulenc Rorer Inc has named Manfred Karobath as senior vice president, RPR, and president, RPR Research and Development. He was...

APPOINTMENTS AT AKZO

6 April 1992

Akzo NV of the Netherlands has appointed Lodewijk van Wachem and Abraham Cohen as members of its supervisory board.

PA CONSULTING GROUP APPOINTMENTS

6 April 1992

Appointed as senior associates for the pharmaceutical industry at PA Consulting Group are Keith Mansford, former chairman of R&D...

FURTHER FALLS FOR DEPRENYL?

6 April 1992

Shares of the Canadian biopharmaceutical company Deprenyl Re-search have recently lost value and could well fall further, according to local...

AUSTRALIAN DRUG PROMOTION STUDY

6 April 1992

In Australia, a parliamentary report from the House of Representatives concludes that there is no evidence that hospitality provided...

SANDOZ 1991 EARNINGS JUMP 15%

6 April 1992

Swiss pharmaceutical major Sandoz reported a 15% rise in net profit to 1.11 billion Swiss frances ($732.0 million) for 1991,...

BETA BLOCKERS AND DEPRESSION

6 April 1992

Commonly prescribed beta blockers used to treat conditions such as hypertension, angina and migraine do not cause depression, according to...

Showing 94491-94500 of 95329 articles